Search results
ESC 2024: Latest FLOW trial analysis highlights how Ozempic can benefit CKD patients
Pharmaceutical Technology· 7 days agoIn March 2024, Novo announced positive results from the kidney outcomes trial FLOW...CKD. FLOW was a...
ESC 2024: FINEARTS-HF trial sheds positive light on Kerendia for HFmrEF/HFpEF
Clinical Trials Arena· 5 days ago-HF is a randomised, double-blind, placebo-controlled, multicenter, event-driven Phase III trial to...
Combating Pharmaceutical Crime with On-Dose Authentication
Pharmaceutical Technology· 2 days agoDespite the best efforts of pharmaceutical manufacturers and regulators to improve the security and...
Paul Mitchell: Newcastle’s Transfer Strategy “Not Fit for Purpose”
EPL Index· 2 days agoNewcastle’s Transfer Strategy: A Reflection on Its Fitness for PurposeEvaluating the Magpies’...
J&K Reorganization Act was a Political Fraud That Makes Elections Irrelevant - Kashmir Times (Since...
Kashmir Times· 4 days ago“The conspicuous absence of an elected legislature since June 2018 encapsulates a pervasive ethos...
Growing crimes against minors & Meghalaya’s legal dilemma surrounding adolescent love - The Shillong...
Shillong Times· 3 days agoThis dichotomy necessitates a critical analysis of the legal framework, social practices, and their ...